Saudi German Health (SGH) has signed a Memorandum of Understanding (MoU) with Becton, Dickinson and Company (BD), a global leader in advanced healthcare solutions, in order to transform healthcare services by introducing rapid diagnostic solutions.
The MoU was signed by Dr Ahmed Shebl, Group CEO of Saudi German Health, and Riza Mutlak, Business Director at BD – Middle East, North Africa & Turkey, during a ceremony held recently at SGH’s headquarters in Jeddah.
This collaboration is the first of its kind in the region, setting a new precedent for future innovations in healthcare. With an emphasis on state-of-the-art laboratory technologies, it will introduce advanced devices such as Bactec, Phoenix, Epicenter, and MALDI-TOF to significantly enhance diagnostic capabilities and improve patient care.
The partnership aims to address existing challenges in microbiology by providing rapid and precise diagnostic solutions, thus establishing new standards for healthcare efficiency. The launch of these innovative lab devices will allow SGH to provide quicker, more accurate diagnoses, enhancing patient outcomes and elevating the quality of healthcare throughout the region.
